Advertisement

Serotonin Syndrome

  • Mark Forrest Gordon
  • Adena Leder
Part of the Current Clinical Neurology book series (CCNEU)

Abstract

Patient 1: A 34-year-old woman had a history of migraine with aura since age 16 and recent postpartum depression. Approximately 6 months ago, she started fluoxetine for depression and migraine prophylaxis. At her most recent clinic appointment, she also started sumatriptan to abort her migraines. Two weeks later, 1 hour after her third subcutaneous 6-mg dose of sumatriptan, she presented to the emergency room. Her exam showed diaphoresis, agitation, confusion, dysarthria, staggering gait, and occasional myoclonic jerks in the legs.

Keywords

Raphe Nucleus Migraine With Aura Neuroleptic Malignant Syndrome Serotonin Syndrome Ecstasy User 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Oates JA, Sjoerdsma A. Neurologic effects of tryptophan in patients receiving a monoamine oxidase inhibitor. Neurology 1960;10:1076–1078.PubMedGoogle Scholar
  2. 2.
    Mills KC. Serotonin syndrome. American Family Physician 1995;52:1475–1482.PubMedGoogle Scholar
  3. 3.
    Sternbach H. The serotonin syndrome. Am J Psychiatry 1991;148:705–713.PubMedGoogle Scholar
  4. 4.
    Harrison’s Principles of Internal Medicine. 15th edition. Braunwald E, Stone RM, Fauci AS, Hauser SL, Jameson JL, eds. McGraw-Hill, New York: 2001.Google Scholar
  5. 5.
    Siegel GJ, Albers RW, Agranoff BW, et al. Basic Neurochemistry: Molecular, Cellular, and Medical Aspects. 6th edition. Lippincott-Raven, Philadelphia: 1999.Google Scholar
  6. 6.
    Gillman, PK. Serotonin syndrome: clomipramine too soon after moclobemide. Int Clin Psychopharmacol 1997;12:339–342.PubMedCrossRefGoogle Scholar
  7. 7.
    Toyama SC, Iacono RP. Is it safe to combine a selective serotonin reuptake inhibitor with selegiline? Ann Pharmacother 1994;28:405.PubMedGoogle Scholar
  8. 8.
    Waters CH. Fluoxetine and selegiline-lack of significant interaction. Can J Neurol Sci 1994;21:259–261.PubMedGoogle Scholar
  9. 9.
    Zornberg GL, Bodkin JA, Cohen BM. Severe adverse interaction between pethidine and selegiline. Lancet 1991;337:246.PubMedCrossRefGoogle Scholar
  10. 10.
    Durson SM, Mathew VM, Reveley MA. Toxic serotonin syndrome after fluoxetine plus carbamazepine. Lancet 1993;342:442–443.CrossRefGoogle Scholar
  11. 11.
    Parker V, Wong AHC, Boon HS, Seeman MV. Adverse reactions to St John’s Wort. Can J Psychiatry 2001;46:77–79.PubMedGoogle Scholar
  12. 12.
    Task Force on DSM-IV. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR). American Psychiatric Association, 2000.Google Scholar
  13. 13.
    Gardner DM, Lynd LD. Sumatriptan contraindications and the serotonin syndrome. Ann Pharmacother 1998;32:33–38.PubMedCrossRefGoogle Scholar
  14. 14.
    Mathew NT, Tietjen GE, Lucker C. Serotonin syndrome complicating migraine pharmacotherapy. Cephalalgia 1996;16:323–327.PubMedCrossRefGoogle Scholar
  15. 15.
    DeSilva KE, Le Flore DB, Marston BJ, Rimland D. Serotonin syndrome in HIV-infected individuals receiving antiretroviral therapy and fluoxetine. AIDS 2001;15:1281–1285.PubMedCrossRefGoogle Scholar
  16. 16.
    Parrott AC. Recreational Ecstasy/MDMA, the serotonin syndrome, and serotonergic neurotoxicity. Pharmacol Biochem Behav 2002;71:837–844.PubMedCrossRefGoogle Scholar
  17. 17.
    Randall T. Ecstasy-fueled “rave” parties become dances of death for English youths JAMA 1992;268:1505–1506.PubMedCrossRefGoogle Scholar
  18. 18.
    Gill M, Lo Vecchio F, Seldan B. Serotonin syndrome in a child after a single dose of fluvoxamine. Ann Emerg Med 1999;33:457–459.PubMedCrossRefGoogle Scholar
  19. 19.
    Spirko BA, James FW. Serotonin syndrome: A new pediatric intoxication. Pediatr Emerg Care 1999;15(6):440–443.PubMedCrossRefGoogle Scholar
  20. 20.
    Graudins A, Stearman, Chan B. Treatment of the serotonin syndrome with cyproheptadine. J Emerg Med 1998;16:615–619.PubMedCrossRefGoogle Scholar
  21. 21.
    Nisijima K, Nibuya M, Kato S. Toxic serotonin syndrome successfully treated with electroconvulsive therapy. J Clin Psychopharmacol 2002;22:338–339.PubMedCrossRefGoogle Scholar

Copyright information

© Humana Press Inc. 2005

Authors and Affiliations

  • Mark Forrest Gordon
    • 1
  • Adena Leder
    • 1
  1. 1.Department of NeurologyLong Island Jewish Medical CenterNew Hyde Park

Personalised recommendations